C reactive protein flare predicts response to checkpoint inhibitor treatment in non-small cell lung cancer

Biomarkers for predicting response to anti-programmed death-1 (PD-1) immune checkpoint blockade (ICB) in non-small cell lung cancer (NSCLC) remain in demand. Since anti-tumor immune activation is a process, early dynamic changes of the acute-phase reactant C reactive protein (CRP) may serve as a pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Klümper, Niklas, Saal, Jonas, Berner, Fiamma, Lichtensteiger, Christa, Wyss, Nina, Heine, Annkristin, Bauernfeind, Franz Georg, Ellinger, Jörg, Brossart, Peter, Diem, Stefan, Schmid, Sabine, Joerger, Markus, Frueh, Martin, Ritter, Manuel, Hölzel, Michael, Flatz, Lukas, Bald, Tobias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Immunotherapy Biomarkers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8928397/
https://www.ncbi.nlm.nih.gov/pubmed/35292517
http://dx.doi.org/10.1136/jitc-2021-004024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8928397/
https://www.ncbi.nlm.nih.gov/pubmed/35292517
http://dx.doi.org/10.1136/jitc-2021-004024

Ejemplares similares